Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G/A for Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD).
- Disclosed ownership: 7.1%.
- Date of event: 30 Jun 2025.
CVI Investments, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- GLMD
- Shares outstanding
- 2,441,310 shares
- Disclosed Ownership
- 173,333 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 14:01:00 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 7.1% ownership in Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 14:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 7.1% | 173,333 | 0 | 173,333 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 7.1% | 173,333 | 0 | 173,333 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary |